Absci Corp (ABSI)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
4.19
-0.02
(-0.48%)
After-Hours: 20:00
Absci Total Assets (Quarterly): 274.90M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 274.90M |
December 31, 2023 | 217.30M |
September 30, 2023 | 236.34M |
June 30, 2023 | 254.15M |
March 31, 2023 | 295.81M |
December 31, 2022 | 321.01M |
September 30, 2022 | 339.39M |
Date | Value |
---|---|
June 30, 2022 | 366.32M |
March 31, 2022 | 395.46M |
December 31, 2021 | 426.20M |
September 30, 2021 | 449.12M |
June 30, 2021 | 257.07M |
March 31, 2021 | 222.83M |
December 31, 2020 | 88.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
88.57M
Minimum
Dec 2020
449.12M
Maximum
Sep 2021
296.03M
Average
285.35M
Median
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 63.94B |
Creative Medical Technology Holdings Inc | 9.620M |
CytomX Therapeutics Inc | 184.69M |
Bristol-Myers Squibb Co | 99.03B |
Recursion Pharmaceuticals Inc | 557.85M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 34.79M |
Shareholders Equity (Quarterly) | 240.11M |
Debt to Equity Ratio | 0.0293 |
Current Ratio | 7.189 |
Net Debt Paydown Yield | 0.12% |